TABLE 3.

Primers used in this study

PrimerSequencea
Znc2-5-BamBGCAAGGATCCAAGAAGAAGTGGATAATTTTGATTAAC
Znc2-3-XhoGCAACTCGAGAGTATATTCTGTTGGGAAAGGGGTGAG
Znc2-GST1AGCAAGGATCCATGGACACTTCACTGTCACTGGGA
Znc2-GST2GCTTTCTCGAGACTTGATTTGTTGTCATTTATGCCG
CDR1-FCATGGTCAAGCCATTTTGTG
CDR1-RATCCATTCTGCTGGATTTGC
CDR2-FCATGGTCAAGCCATTTTGTG
CDR2-RATCCATTCTGCTGGATTTGC
IFU5-FAAACCCACCACAAGTTCCTG
IFU5-RCTTGGGGCATTAGACCTTGA
RTA3-FTACAGAATGGACTCCTACCT
RTA3-RGCCGTACGATTTAATCGA
CDR1-PSTGCGCAAACTGCAGAATTTTTTTCTTTTTGACCTTTTAAAGAAA
CDR1-KPNGCGCAAAGGTACCGGATCCTCGTTACTCAATAAGTATTAATTG
CDR2-PSTGCGCAAACTGCAGATGTTTTTATTGTATGTGTTAATTAGTGAA
CDR2-KPNGCGCAAAGGTACCGGTTCCTCTAAATAAAAACTAGAAGGTTAT
CDR2-HINDGCGCAAAGCTTTGTTGTGACTTGCAGTAGCAT
CDR2-PST-900GCAAACTGCAGGTTCCTCTAAATAAAAACTAGAAGG
CDR2-DEL5GTATTAATTTTTACGTATTTTCTTTGTGTTATTCAATTCTTGTTTTCAAAGCCT
CDR2-DEL3AGTATTCATAATAGAGGCTTTGAAAACAAA
CDR2-XHOGCGCAAACTCGAGACATGAAAAATGAAATCAATTCAAACACAA
CDR2-ANTIAATGTTTTTATTGTATGTGTTAATTAGTGAA
CDR2-LACZAACACATACAATAAAAACATATGAACATGACTGAAAAAATTCAAACTT
CDR2-SACGCGCAAAGAGCTCACATGAAAAATGAAATCAATTCAAACACAA
MAL2-BAMGCGCAAAGGATCCCATACGCTTTGCAGGTGGTGTTGATCC
SALI-ZNC2CGCGCAAAGTCGACATAATGGACACTTCACTGTCACTGGGA
SPHI-ZNC2CGCGCAAAGCATGCAAATCCCCAAATTATTGTCAAAGAAAAA
GFP-5-SPHICGCGAAAGCATGCATTCTAAAGGTGAAGA
GFP-3-NHECGCGAAAGCTAGCTTATTTGTACAATTCATCCATACCATGGG
  • a Restriction sites are underlined.